Logo

Course

Stimulant Use Disorder: Clinical Practice Guidelines for the Primary Care Provider - Part 1

Details

Published Date: 05/01/2026

CE Credit: No CE

Description

Stimulant use in the U.S.—especially methamphetamine and cocaine—has risen sharply in recent years, often alongside opioid use, contributing to a growing number of polysubstance overdoses. From 2020 to 2021, stimulant-related deaths increased dramatically, with cocaine involved in nearly half of New York City’s overdose deaths, disproportionately affecting Black residents. Stimulant use can lead to severe medical and psychiatric complications, yet no FDA-approved medications currently exist for treatment. As the overdose epidemic becomes more complex, clinicians—particularly in primary care—need targeted training on identifying, treating, and managing stimulant use disorder through behavioral therapies and harm reduction approaches.

Presenter(s)

Linda Wang,MD

Linda Wang, MD is a general internist and addiction medicine specialist who cares for people who use drugs at the REACH Program at Mount Sinai, where she also directs the buprenorphine treatment program. She received her medical degree from the Icahn School of Medicine at Mount Sinai and completed internal medicine residency and chief residency in the Primary Care and Social Internal Medicine Program at Montefiore Medical Center in the Bronx. She is the Medical Director for the Mount Sinai Hepatitis C and Drug User Health Center of Excellence, which is funded by the New York State Department of Health AIDS Institute. She is the Chair of the New York State Drug User Health Working Group. She is an active clinician educator who is interested in expanding access to substance use disorder treatment, providing stigma-free care for people who use drugs, and training current and future clinicians in drug user health.

Daniel Suter,MD

Daniel Suter, MD is an Addiction Psychiatrist working in a Collaborative and Integrated Care program at Mount Sinai Hospital. He completed his medical school at the University of Pittsburgh and his Residency training at Mount Sinai Hospital, followed by an Addiction Psychiatry Fellowship at the Addiction Institute of Mount Sinai. He has practiced in both inpatient and outpatient addiction and psychiatry settings and has a passion for increasing access to mental health care through integrative care models and provider education. 

Kelly Ramsey,MD, MPH, MA, FACP, DFASAM

Kelly S. Ramsey, MD, MPH, MA, FACP, DFASAM is a board-certified internal medicine and addiction medicine physician who has treated substance use disorder since 2004. She currently works as an Addiction Medicine Physician and Addiction Medicine and Harm Reduction Consultant, providing low threshold clinical care and supervision in two drug user health hubs in New York. Dr. Ramsey previously worked as the Chief of Medical Services at the New York State Office of Addiction Services and Supports (OASAS), the single state agency for the addiction services continuum of care, in a policy, regulatory, and clinical role. Dr. Ramsey has been an ardent harm reductionist for over 30 years since she volunteered at the Santa Cruz Needle Exchange in the mid-1990s. She has provided expert advice to the New York State Department of Health (NYSDOH) AIDS Institute and their Office of Drug User Health, serving on numerous committees for over 15 years, providing expertise in addiction medicine, harm reduction, HIV care, and hepatitis C care.

Continuing Education Credit Information